https://www.optimumcomms.com/wp-content/uploads/2023/06/Destiny_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-07-06 09:02:092023-07-06 09:02:09Destiny Pharma plc – Positive findings from recent SAB meeting
https://www.optimumcomms.com/wp-content/uploads/2023/06/Sequana_Medical_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-07-06 08:11:022023-07-06 08:11:02Sequana Medical – 1,000th alfapump® implant completed
https://www.optimumcomms.com/wp-content/uploads/2023/02/Pheon_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-07-05 13:05:032023-07-05 13:05:32Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals
https://www.optimumcomms.com/wp-content/uploads/2023/02/Biocomposites_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-07-05 08:55:192023-07-05 08:55:32Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform
https://www.optimumcomms.com/wp-content/uploads/2023/06/DelSiTech_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-29 10:06:082023-07-04 17:18:08DelSiTech Announces Positive Topline Clinical Data From Phase 1 Trial With Its Sustained Release Eye Drop Platform
https://www.optimumcomms.com/wp-content/uploads/2023/06/Destiny_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-29 09:05:272023-06-29 09:05:27Destiny Pharma plc – Business Update
https://www.optimumcomms.com/wp-content/uploads/2023/06/Template_Logo_300x180px-80x80Web_Logos-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-29 08:00:092023-06-29 07:16:55Vesalius Biocapital Announces First Close of Fourth Fund Raising EUR 95 Million
https://www.optimumcomms.com/wp-content/uploads/2023/06/Poolbeg_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-29 07:12:542023-06-29 07:12:54Poolbeg Pharma plc – Successful Artificial Intelligence led programme identifies multiple influenza drug targets
https://www.optimumcomms.com/wp-content/uploads/2023/06/MinervaX_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-27 10:32:452023-06-28 09:14:13MinervaX Announces Completion of Enrolment in Phase 1 Clinical Vaccine Trial as it Addresses the Global Burden of Group B Streptococcus in Older Adults
https://www.optimumcomms.com/wp-content/uploads/2023/06/Template_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-27 07:08:312023-06-28 09:16:24Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform
https://www.optimumcomms.com/wp-content/uploads/2023/02/Alchemab_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-22 10:07:422023-06-22 10:07:42Alchemab Therapeutics unveils Alzheimer’s candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium
https://www.optimumcomms.com/wp-content/uploads/2023/06/Sequana_Medical_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-22 09:14:362023-06-22 09:14:36Sequana Medical announces additional data on safety, quality of life and survival from North American pivotal alfapump® study (POSEIDON)
https://www.optimumcomms.com/wp-content/uploads/2023/06/Poolbeg_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-22 08:11:222023-06-22 08:11:22Poolbeg Pharma Plc – Oral Vaccine Programme Moves Forward
https://www.optimumcomms.com/wp-content/uploads/2023/06/Calliditas_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-21 15:28:572023-06-21 15:28:57Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®
https://www.optimumcomms.com/wp-content/uploads/2023/06/Novo_Holdings23_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-21 15:25:322023-06-21 15:25:32Novo Holdings to acquire Ellab
https://www.optimumcomms.com/wp-content/uploads/2023/06/Versameb_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-21 08:55:462023-06-21 09:14:24Versameb Appoints Professor Roger Dmochowski as Chief Medical Officer
https://www.optimumcomms.com/wp-content/uploads/2023/06/Sequana_Medical_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-20 11:43:512023-06-21 09:13:16Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards
https://www.optimumcomms.com/wp-content/uploads/2023/06/SpliceBio_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-20 08:45:472023-06-21 09:12:26SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program
https://www.optimumcomms.com/wp-content/uploads/2023/06/adcendo_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-06-20 08:07:012023-06-21 09:11:51Adcendo Appoints Experienced Drug Developer Dr. Lone H. Ottesenas Chief Medical Officer
https://www.optimumcomms.com/wp-content/uploads/2023/02/Nordic-Bioscinece_Logo_300x180px-2.png
180
300
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-06-15 11:06:172023-06-19 15:20:43Nordic Bioscience receives Letter of Support from the FDA for the PRO-C3 biomarker in tumor fibrosisFor more information about Optimum Strategic Communications, please get in touch.
